Clinical Trial: Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975410) titled 'Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors' on April 28.

Brief Summary: This is a study for people with locally advanced or metastatic cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with Epidermal Growth Factor Receptor (EGFR) overexpressing can join the study. The purpose of this study is to find out whether a medicine called YH32364 helps people with locally advanced or metastatic cancers with EGFR overexpression.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: EGFR Overexpression Locally Advan...